Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism
Year: 2024
Type: editorial
Abstract: Benefits and limitations in using NCCN guidelines to distinguish TP53 CH from mosaic LFS.
Source: JCO Precision Oncology
DOI: 10.1200/po.24.00006
Authors: Daniel I. Nathan, Tehilla Brander, Julie Gold, Deborah Paul, Paula Klein, Kit Cheng, Johnson M. Liu, Bridget K. Marcellino
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4400523293
